Immunologically mediated photodermatoses: diagnosis and treatment.

Am J Clin Dermatol

Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.

Published: July 2009

Electromagnetic radiation may cause distinct skin conditions. The immunologically mediated photodermatoses (IMP, previous term: idiopathic photodermatoses) represent a heterogenous group of disorders presenting with pathologic skin reactions caused by optical radiation, particularly in the UVA wavelength region. The exact pathomechanism in IMP remains to be elucidated; however, it is very likely (auto)-immunologic in nature. Polymorphic light eruption, actinic prurigo, hydroa vacciniforme, chronic actinic dermatitis, and solar urticaria are the most important conditions that may be summarized under the term IMP. IMP frequently result in a significant reduction in quality of life in affected individuals, mainly because of troublesome symptoms such as intractable itch and pain. Photodiagnostic procedures are mandatory for the exact determination of action spectra and the degree of photosensitivity. Broad-spectrum photoprotection is essential in the prevention of IMP. Photo(chemo)therapeutic regimens are predominantly used to increase the cutaneous immunologic tolerance against ambient UV radiation. In severe forms of IMP, immunomodulatory and immunosuppressive therapies may need to be considered. Overall, IMP form a significant group of skin conditions that can be extremely disabling to the patient and are difficult to diagnose and treat.

Download full-text PDF

Source
http://dx.doi.org/10.2165/00128071-200910030-00003DOI Listing

Publication Analysis

Top Keywords

immunologically mediated
8
mediated photodermatoses
8
skin conditions
8
imp
7
photodermatoses diagnosis
4
diagnosis treatment
4
treatment electromagnetic
4
electromagnetic radiation
4
radiation distinct
4
distinct skin
4

Similar Publications

Neisseria gonorrhoeae, which causes the sexually transmitted infection gonorrhea and Neisseria meningitidis, a leading cause of bacterial meningitis and septicemia, are closely related human-restricted pathogens that inhabit distinct primary mucosal niches. While successful vaccines against invasive meningococcal disease have been available for decades, the rapid rise in antibiotic resistance has led to an urgent need to develop an effective gonococcal vaccine. Several surface antigens are shared among these two pathogens, making cross-species protection an exciting prospect.

View Article and Find Full Text PDF

Acute inflammation induces acute megakaryopoiesis with impaired platelet production during fetal hematopoiesis.

Development

January 2025

Institute for Regenerative Medicine, State Key Laboratory of Cardiology and Medical Innovation Center, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.

Hematopoietic development is tightly regulated by various factors. The role of RNA m6A modification during fetal hematopoiesis, particularly in megakaryopoiesis, remains unclear. Here, we demonstrate that loss of m6A methyltransferase METTL3 induces formation of double-stranded RNAs (dsRNAs) and activates acute inflammation during fetal hematopoiesis.

View Article and Find Full Text PDF

Opportunities and limitations of B cell depletion approaches in SLE.

Nat Rev Rheumatol

January 2025

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

B cell depletion with rituximab, a chimeric monoclonal antibody that selectively targets B cells by binding CD20, has been used off label in severe and resistant systemic lupus erythematosus (SLE) for over two decades. Several biological mechanisms limit the efficacy of rituximab, including immunological reactions towards the chimeric molecule, increased numbers of residual B cells, including plasmablasts and plasma cells, and a post-treatment surge in B cell-activating factor (BAFF) levels. Consequently, rituximab induces remission in only a proportion of patients, and safety issues limit its use.

View Article and Find Full Text PDF

Patients with post-COVID condition (PCC) present with diverse symptoms which persist at long-term after SARS-CoV-2 infection. Among these symptoms, cognitive impairment is one of the most prevalent and has been related to brain structural and functional changes. The underlying mechanisms of these cognitive and brain alterations remain elusive but neuroinflammation and immune mechanisms have been majorly considered.

View Article and Find Full Text PDF

Microglial NLRP3-gasdermin D activation impairs blood-brain barrier integrity through interleukin-1β-independent neutrophil chemotaxis upon peripheral inflammation in mice.

Nat Commun

January 2025

Department of Microbiology and Immunology, Brain Korea 21 Project for Medical Science, Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea.

Blood-brain barrier (BBB) disintegration is a key contributor to neuroinflammation; however, the biological processes governing BBB permeability under physiological conditions remain unclear. Here, we investigate the role of NLRP3 inflammasome in BBB disruption following peripheral inflammatory challenges. Repeated intraperitoneal lipopolysaccharide administration causes NLRP3-dependent BBB permeabilization and myeloid cell infiltration into the brain.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!